R. Mark Adams - 14 Jun 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role: Chief Operating Officer
Signature: /s/ R. Mark Adams by Eric Billings, attorney-in-fact
Issuer symbol: ADPT
Transactions as of: 14 Jun 2021
Net transactions value: -$345,596
Form type: 4
Filing time: 16 Jun 2021, 19:00:15 UTC
Next filing: 21 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADPT	Common Stock	Sale	$345,596	-8,914	-13%	$38.77^*	58,104	14 Jun 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.
F2	The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $38.31 to 39.22, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

Content

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021.

The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $38.31 to 39.22, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.